TARS vs. CALM
TARS (Tarsus Pharmaceuticals, Inc.) and CALM (Cal-Maine Foods, Inc.) are both stocks. TARS operates in Biotechnology (Healthcare), while CALM operates in Farm Products (Consumer Defensive). Over the past 5 years, TARS returned 21.21%/yr vs 26.60%/yr for CALM. Their 0.03 correlation means their historical movements had little consistent relationship.
Performance
TARS vs. CALM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TARS achieves a -27.89% return, which is significantly lower than CALM's 11.79% return.
TARS
- 1D
- -0.84%
- 1M
- -9.78%
- 6M
- -8.52%
- YTD
- -27.89%
- 1Y
- 44.67%
- 3Y*
- 47.84%
- 5Y*
- 21.21%
- 10Y*
- —
- ALL TIME*
- 25.04%
CALM
- 1D
- 0.80%
- 1M
- 4.69%
- 6M
- 5.58%
- YTD
- 11.79%
- 1Y
- -14.37%
- 3Y*
- 31.12%
- 5Y*
- 26.60%
- 10Y*
- 10.82%
- ALL TIME*
- 16.54%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $107.67M | $90.60M | $71.32M | |
| $50.18M | $76.91M | $59.68M |
TARS vs. CALM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
TARS Tarsus Pharmaceuticals, Inc. | -27.89% | 47.88% | 173.43% | 38.13% | -34.84% | -45.56% | 155.12% |
CALM Cal-Maine Foods, Inc. | 11.79% | -15.61% | 87.00% | 14.48% | 51.87% | -1.38% | -1.65% |
Correlation
The correlation between TARS and CALM is 0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.02 |
Correlation (3Y) Balances recent behavior with more history. | 0.05 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.04 |
Correlation (All Time) Calculated using the full available price history since Oct 16, 2020 | 0.03 |
Fundamentals
TARS:
$2.54B
CALM:
$4.12B
TARS:
-$1.13
CALM:
$6.63
TARS:
4.72
CALM:
1.44
TARS:
7.27
CALM:
1.57
TARS:
$535.08M
CALM:
$2.91B
TARS:
$483.93M
CALM:
$672.05M
TARS:
-$39.55M
CALM:
$515.05M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TARS vs. CALM — Risk / Return Rank
TARS
CALM
TARS vs. CALM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tarsus Pharmaceuticals, Inc. (TARS) and Cal-Maine Foods, Inc. (CALM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TARS | CALM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.70 | ||
| Sortino ratioReturn per unit of downside risk | +2.49 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 0.93 | +0.29 |
| Calmar ratioReturn relative to maximum drawdown | 1.64 | -0.46 | +2.09 |
| Martin ratioReturn relative to average drawdown | 3.16 | -0.66 | +3.82 |
Loading charts...
Drawdowns
TARS vs. CALM - Drawdown Comparison
The maximum TARS drawdown since its inception was -77.67%, roughly equal to the maximum CALM drawdown of -74.08%. Use the drawdown chart below to compare losses from any high point for TARS and CALM.
Loading charts...
Drawdown Indicators
| TARS | CALM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.67% | -74.08% | -3.59% |
Max Drawdown (1Y)Largest decline over 1 year | -32.00% | -37.00% | +5.00% |
Max Drawdown (3Y)Largest decline over 3 years | -45.08% | -37.00% | -8.08% |
Max Drawdown (5Y)Largest decline over 5 years | -62.67% | -37.00% | -25.67% |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.12% | — |
Current DrawdownCurrent decline from peak | -28.45% | -22.64% | -5.81% |
Average DrawdownAverage peak-to-trough decline | -40.18% | -30.29% | -9.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.51% | 25.62% | -9.11% |
Volatility
TARS vs. CALM - Volatility Comparison
Tarsus Pharmaceuticals, Inc. (TARS) has a higher volatility of 18.88% compared to Cal-Maine Foods, Inc. (CALM) at 13.24%. This indicates that TARS's price experiences larger fluctuations and is considered to be riskier than CALM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TARS | CALM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.88% | 13.24% | +5.64% |
Volatility (6M)Calculated over the trailing 6-month period | 33.36% | 22.88% | +10.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.36% | 30.03% | +16.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.69% | 33.05% | +25.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 64.62% | 31.34% | +33.28% |
Dividends
TARS vs. CALM - Dividend Comparison
TARS has not paid dividends to shareholders, while CALM's dividend yield for the trailing twelve months is around 5.47%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CALM Cal-Maine Foods, Inc. | 5.47% | 10.90% | 2.82% | 7.51% | 3.17% | 0.09% | 0.00% | 0.98% | 1.03% | 0.00% | 2.70% | 4.10% |
TARS Tarsus Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
TARS vs. CALM - Financials Comparison
This section allows you to compare key financial metrics between Tarsus Pharmaceuticals, Inc. and Cal-Maine Foods, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TARS vs. CALM - Profitability Comparison
TARS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Tarsus Pharmaceuticals, Inc. reported a gross profit of 152.66M and revenue of 162.05M. Therefore, the gross margin over that period was 94.2%.
CALM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Cal-Maine Foods, Inc. reported a gross profit of 34.07M and revenue of 552.58M. Therefore, the gross margin over that period was 6.2%.
TARS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Tarsus Pharmaceuticals, Inc. reported an operating income of -6.12M and revenue of 162.05M, resulting in an operating margin of -3.8%.
CALM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Cal-Maine Foods, Inc. reported an operating income of -61.02M and revenue of 552.58M, resulting in an operating margin of -11.0%.
TARS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Tarsus Pharmaceuticals, Inc. reported a net income of -6.97M and revenue of 162.05M, resulting in a net margin of -4.3%.
CALM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Cal-Maine Foods, Inc. reported a net income of -35.88M and revenue of 552.58M, resulting in a net margin of -6.5%.
Frequently Asked Questions
TARS and CALM have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TARS has higher volatility (18.88%) compared to CALM (13.24%). In terms of maximum drawdown, TARS dropped -77.67% vs CALM's -74.08%.
TARS currently has the higher Sharpe Ratio (1.13 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TARS and CALM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer